Biosynthesis and biotransformation of ether lipids Helmut K. MangoldNikolaus Weber Review Pages: 789 - 799
The degradation of platelet-activating factor and related lipids: Susceptibility to phospholipases C and D Rebecca W. WilcoxRobert L. WykleLarry W. Daniel OriginalPaper Pages: 800 - 807
Enzymatic acylation of ether and ester lysophospholipids in rat liver microsomes W. NeumüllerE. A. M. FleerH. Eibl OriginalPaper Pages: 808 - 812
Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells Joachim StorchPaul G. Munder OriginalPaper Pages: 813 - 819
Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion Wim J. van BlitterswijkHenk HilkmannGuy A. Storme OriginalPaper Pages: 820 - 823
A continuous assay forO-alkylglycerol monooxygenase (E.C. 1.14.16.5) Jochem KoettingClemens UngerHansjoerg Eibl OriginalPaper Pages: 824 - 830
Substrate specificity ofO-alkylglycerol monooxygenase (E.C. 1.14.16.5), solubilized from rat liver microsomes Jochem KöttingClemens UngerHansjörg Eibl OriginalPaper Pages: 831 - 835
Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2 Reinhard AndreesenVeronika Giese OriginalPaper Pages: 836 - 841
A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C Wim J. van BlitterswijkRob L. van der BendJohn de Widt OriginalPaper Pages: 842 - 846
Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types Guy A. StormeErik A. BruyneelMarc M. Mareel OriginalPaper Pages: 847 - 850
Ether lipids inhibit the effects of phorbol diester tumor promoters Larry W. DanielLori A. EtkinClaude Plantadosi OriginalPaper Pages: 851 - 855
Metabolism of ether phospholipids and analogs in neoplastic cells E. A. M. FleerC. UngerH. Eibl OriginalPaper Pages: 856 - 861
Antitumor activity of synthetic alkylphospholipids with or without PAF activity Ichiro KudoShoshichi NojimaKeizo Inoue OriginalPaper Pages: 862 - 867
Effect of synthetic phospholipids on platelet aggregation and serotonin release Ulrike SölingHansjörg EiblClemens Unger OriginalPaper Pages: 868 - 870
Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice James E. TalmadgeMark SchneiderCedric Long OriginalPaper Pages: 871 - 877
Neoplastic cell inhibition with new ether lipid analogs Alessandro NosedaMichael E. BerensEdward J. Modest OriginalPaper Pages: 878 - 883
Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3 William J. HoulihanMark L. LeeChristian Jaeggi OriginalPaper Pages: 884 - 890
Liposomes in chemo- and immunotherapy of cancer Gerrit L. ScherphofToos DaemenFrits H. Roerdink OriginalPaper Pages: 891 - 896
Cytostatic activity of syntheticO-alkylglycerolipids Hans BrachwitzPeter LangenIduna Fichtner OriginalPaper Pages: 897 - 903
Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro Hans D. SchickWolfgang E. BerdelJohann Rastetter OriginalPaper Pages: 904 - 910
Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro Susanne DanhauserWolfgang E. BerdelJohann rastetter OriginalPaper Pages: 911 - 915
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro Michael FrommWolfgang E. BerdelJohann Rastetter OriginalPaper Pages: 916 - 918
Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplatation William R. VoglerAnita C. OlsonLewis Glasser OriginalPaper Pages: 919 - 924
Distribution and metabolism of hexadecylphosphocholine in mice A. BreiserD. -J. KimC. Unger OriginalPaper Pages: 925 - 926
Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats H. R. ScherfB. SchulerD. Schmähl OriginalPaper Pages: 927 - 929
Alkyl phosphocholines: Toxicity and anticancer properties C. MuschiolM. R. BergerD. Schmähl OriginalPaper Pages: 930 - 934
Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids Martin R. BergerDietrich Schmähl OriginalPaper Pages: 935 - 942
Antineoplastic activity of conjugates of lipids and 1-β-d-arabinofuranosylcytosine Wolfgang E. BerdelSusanne DanhauserJohann Rastetter OriginalPaper Pages: 943 - 946
Synthesis of thioether phosphocholine analogues Elmar BosiesDieter B. J. HerrmannWulf Pahlke OriginalPaper Pages: 947 - 951
Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in rats Dieter B. J. HerrmannEberhard BesenfelderErwin Böhm OriginalPaper Pages: 952 - 954
Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures Dieter B. J. HerrmannHerbert A. Neumann OriginalPaper Pages: 955 - 957
In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440 G. H. LederH. H. FiebigG. W. Löhr OriginalPaper Pages: 958 - 961
Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients Dieter B. J. HerrmannHerbert A. NeumannUwe Bicker OriginalPaper Pages: 962 - 966
Clinical phase I pilot study of the alkyl lysophospholipid derivative ET-18-OCH3 1 Wolfgang E. BerdelUlrich FinkJohann Rastetter OriginalPaper Pages: 967 - 969
Ether lipids and analogs in experimental cancer therapy. A brief review of the munich experience Wolfgang E. Berdel Review Pages: 970 - 973